{"name":"Chang, Steve S., M.D.","slug":"chang-steve-s-m-d","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DDAVP","genericName":"DDAVP","slug":"ddavp","indication":"Central diabetes insipidus","status":"marketed"}]}],"pipeline":[{"name":"DDAVP","genericName":"DDAVP","slug":"ddavp","phase":"marketed","mechanism":"DDAVP (desmopressin) is a synthetic vasopressin analog that acts as an antidiuretic hormone (ADH) receptor agonist to increase water reabsorption in the kidneys and promote von Willebrand factor release from endothelial cells.","indications":["Central diabetes insipidus","Nocturnal enuresis","Von Willebrand disease","Hemophilia A","Polycystic kidney disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNWXFzdlMtM1VMZjVkNHNpNzc3WXhGeVNHRGcxWWljQVhDc2x1aW8zMG8zbDFDT1Y2UXVQbDhlRzNQd1BZWkhuaDZUbVUtSC1RRjRFOENpdGVIbURlek92NkFoZ0g5dVhrMy03aEI1SEpfYXJHYUlPeDZfMjdYX1pJM3E3VEpqRml0dEtuUmllSEVwdHYzTGh4MFNqWnhvZw?oc=5","date":"2021-05-26","type":"pipeline","source":"Timmerman Report","summary":"11 Asian-American Executives Shaping the Future of Biopharma - Timmerman Report","headline":"11 Asian-American Executives Shaping the Future of Biopharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}